EI
AMED

Ellevest Inc’s Amedisys AMED Stock Holding History

Ellevest Inc’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8
Closed -$588 – 414
2023
Q1 		$588 Buy
+8
New +$692 ﹤0.01% 1657
2022
Q2 		– Sell
-17
Closed -$3K – 1375
2022
Q1 		$3K Buy
+17
New +$2.54K ﹤0.01% 1112
2021
Q3 		– Sell
-5
Closed -$1K – 1380
2021
Q2 		$1K Sell
5
-3
-38% -$787 ﹤0.01% 1111
2021
Q1 		$2K Buy
8
+4
+100% +$1.13K ﹤0.01% 1030
2020
Q4 		$1K Sell
4
-2
-33% -$513 ﹤0.01% 1023
2020
Q3 		$1K Buy
6
+3
+100% +$682 ﹤0.01% 960
2020
Q2 		$1K Sell
3
-9
-75% -$1.68K ﹤0.01% 948
2020
Q1 		$2K Buy
+12
New +$2.13K ﹤0.01% 742

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Ellevest Inc's AMED Position: Q2 2023 in Review

Ellevest Inc sold out of Amedisys (AMED) in Q2 2023, closing a stake of 8 shares — an estimated $588 sold.

Ellevest Inc first reported a position in AMED in Q1 2020 and held it in 8 quarters. The position peaked at $3K in Q1 2022. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Ellevest Inc reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 8 Amedisys shares in Q2 2023, an estimated $588.
  • Ellevest Inc first reported a position in Amedisys in Q1 2020 and held it in 8 quarters.
  • Ellevest Inc's Amedisys position peaked at $3K in Q1 2022.
  • 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.